During the past decade, Bach and Godofsky conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bach and Godofsky" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Agouron Pharmaceuticals" with 2 trials sponsored, "Bausch Health Americas, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Dupont Applied Biosciences" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

According to Clinical.Site data, the most researched conditions in "Bach and Godofsky" are "HIV Infections" (10 trials), "Hepatitis C, Chronic" (6 trials), "Chronic Hepatitis C" (3 trials), "Chronic Hepatitis C Virus Genotype 1" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Bach and Godofsky" in a lesser frequency.

Most popular intervention types in "Bach and Godofsky" are "Drug" (19 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nelfinavir mesylate" (3 trials), "Ribavirin" (3 trials), "Capravirine" (2 trials), "GS-9451" (2 trials) and "Lamivudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bach and Godofsky" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Bach and Godofsky". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Bach and Godofsky, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bach and Godofsky, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".